Cabozantinib (XL-184) Monotherapy for Advanced Cholangiocarcinoma

Clinical trial NCT01954745 · COMPLETED

Trial details

NCT number: NCT01954745
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Bile Duct Cancer Intrahepatic Cholangiocarcinoma Cholangiocarcinoma of the Extrahepatic Bile Duct

Start date: 2013-09-01
Primary completion: 2015-06-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.